Expression Analysis of an Evolutionarily Conserved Alternative Splicing Factor, Sfrs10, in Age-Related Macular Degeneration

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Karunakaran, Devi Krishna Priya ^a   Banday, Abdul Rouf ^a   Wu, Qian ^b   Kanadia, Rahul ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE ARGININE RICH PROTEIN; SERINE ARGININE RICH SPLICING FACTOR 10; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RETINA; RETINA MACULA AGE RELATED DEGENERATION; SPECIES DIFFERENCE; UPREGULATION; ZEBRA FISH;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHICKENS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACULAR DEGENERATION; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; RATS; RETINA; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY;

EID: 84884797704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075964     Document Type: Article

References (59)

1. Algvere PV, Marshall J, Seregard S, (2006) Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 84: 4-15.
2. Bressler SB, (2009) Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology 116: S1-7.
3. Campochiaro PA, (2004) Ocular neovascularisation and excessive vascular permeability. Expert Opin Biol Ther 4: 1395-1402.
4. Curcio CA, Johnson M, Huang JD, Rudolf M, (2009) Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 28: 393-422.
5. Ding X, Patel M, Chan CC, (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28: 1-18.
6. Feigl B, (2009) Age-related maculopathy- linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 28: 63-86.
7. Verhoeff FH, Grossman HP, (1937) The Pathogenesis of Disciform Degeneration of the Macula. Trans Am Ophthalmol Soc 35: 262-294.
8. Arden GB, Sidman RL, Arap W, Schlingemann RO, (2005) Spare the rod and spoil the eye. Br J Ophthalmol 89: 764-769.
9. Boulton M, Marshall J, (1986) Effects of increasing numbers of phagocytic inclusions on human retinal pigment epithelial cells in culture: a model for aging. Br J Ophthalmol 70: 808-815.
10. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ, (1989) Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 30: 1691-1699.
11. Suter M, Reme C, Grimm C, Wenzel A, Jaattela M, et al. (2000) Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 275: 39625-39630.
12. Berman ER, (1994) Retinal pigment epithelium: lysosomal enzymes and aging. Br J Ophthalmol 78: 82-83.
13. Holz FG, Bellmann C, Margaritidis M, Schutt F, Otto TP, et al. (1999) Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237: 145-152.
14. Bird A, (1996) Age-related macular disease. Br J Ophthalmol 80: 2-3.
15. Guymer R, Luthert P, Bird A, (1999) Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res 18: 59-90.
16. Hogan MJ, (1972) Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol 76: 64-80.
17. Young RW, (1971) The renewal of rod and cone outer segments in the rhesus monkey. J Cell Biol 49: 303-318.
18. Snodderly DM, Sandstrom MM, Leung IY, Zucker CL, Neuringer M, (2002) Retinal pigment epithelial cell distribution in central retina of rhesus monkeys. Invest Ophthalmol Vis Sci 43: 2815-2818.
19. Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA Jr, (2009) Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis 15: 2710-2719.
20. Zareparsi S, Buraczynska M, Branham KE, Shah S, Eng D, et al. (2005) Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 14: 1449-1455.
21. Lazzeri S, Orlandi P, Figus M, Fioravanti A, Cascio E, et al. (2012) The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. ScientificWorldJournal 2012: 420190.
22. Kaur I, Cantsilieris S, Katta S, Richardson AJ, Schache M, et al. (2013) Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration. Mol Vis 19: 822-828.
23. Ricci F, Zampatti S, D'Abbruzzi F, Missiroli F, Martone C, et al. (2009) Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population. Arch Ophthalmol 127: 1368-1372.
24. Lu F, Shi Y, Qu C, Zhao P, Liu X, et al. (2013) A genetic variant in the SKIV2L gene is significantly associated with age-related macular degeneration in a Han Chinese population. Invest Ophthalmol Vis Sci.
25. Nakata I, Yamashiro K, Akagi-Kurashige Y, Miyake M, Kumagai K, et al. (2012) Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populations. Invest Ophthalmol Vis Sci 53: 6576-6581.
26. Zahler AM, Lane WS, Stolk JA, Roth MB, (1992) SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 6: 837-847.
27. Krainer AR, Maniatis T, (1985) Multiple factors including the small nuclear ribonucleoproteins U1 and U2 are necessary for pre-mRNA splicing in vitro. Cell 42: 725-736.
28. Krainer AR, Conway GC, Kozak D, (1990) Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev 4: 1158-1171.
29. Fu XD, Mayeda A, Maniatis T, Krainer AR, (1992) General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc Natl Acad Sci U S A 89: 11224-11228.
30. Fu XD, Maniatis T, (1990) Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343: 437-441.
31. Huang Y, Steitz JA, (2005) SRprises along a messenger's journey. Mol Cell 17: 613-615.
32. Long JC, Caceres JF, (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417: 15-27.
33. Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD, (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35: 1-10.
34. Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, et al. (2011) WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 20: 768-780.
35. Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, et al. (2010) Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285: 5532-5540.
36. Matsuo N, Ogawa S, Imai Y, Takagi T, Tohyama M, et al. (1995) Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/reoxygenation. J Biol Chem 270: 28216-28222.
37. Tsukamoto Y, Matsuo N, Ozawa K, Hori O, Higashi T, et al. (2001) Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation. Am J Pathol 158: 1685-1694.
38. Kiryu-Seo S, Matsuo N, Wanaka A, Ogawa S, Tohyama M, et al. (1998) A sequence-specific splicing activator, tra2beta, is up-regulated in response to nerve injury. Brain Res Mol Brain Res 62: 220-223.
39. Daoud R, Da Penha Berzaghi M, Siedler F, Hubener M, Stamm S, (1999) Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur J Neurosci 11: 788-802.
40. Watermann DO, Tang Y, Zur Hausen A, Jager M, Stamm S, et al. (2006) Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 66: 4774-4780.
41. Segade F, Hurle B, Claudio E, Ramos S, Lazo PS, (1996) Molecular cloning of a mouse homologue for the Drosophila splicing regulator Tra2. FEBS Lett 387: 152-156.
42. Daoud R, Mies G, Smialowska A, Olah L, Hossmann KA, et al. (2002) Ischemia induces a translocation of the splicing factor tra2-beta 1 and changes alternative splicing patterns in the brain. J Neurosci 22: 5889-5899.
43. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, et al. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15: 2087-2097.
44. Landsman D, (1992) RNP-1, an RNA-binding motif is conserved in the DNA-binding cold shock domain. Nucleic Acids Res 20: 2861-2864.
45. Birney E, Kumar S, Krainer AR, (1993) Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res 21: 5803-5816.
46. Bandziulis RJ, Swanson MS, Dreyfuss G, (1989) RNA-binding proteins as developmental regulators. Genes Dev 3: 431-437.
47. Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME, et al. (2008) Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum Mol Genet 17: 52-70.
48. Shelley EJ, Madigan MC, Natoli R, Penfold PL, Provis JM, (2009) Cone degeneration in aging and age-related macular degeneration. Arch Ophthalmol 127: 483-492.
49. Tazi J, Bird A, (1990) Alternative chromatin structure at CpG islands. Cell 60: 909-920.
50. Larsen F, Gundersen G, Lopez R, Prydz H, (1992) CpG islands as gene markers in the human genome. Genomics 13: 1095-1107.
51. Zhang G, Taneja KL, Singer RH, Green MR, (1994) Localization of pre-mRNA splicing in mammalian nuclei. Nature 372: 809-812.
52. Hall LL, Smith KP, Byron M, Lawrence JB, (2006) Molecular anatomy of a speckle. Anat Rec A Discov Mol Cell Evol Biol 288: 664-675.
53. Li SJ, Qi Y, Zhao JJ, Li Y, Liu XY, et al. (2013) Characterization of Nuclear Localization Signals (NLSs) and Function of NLSs and Phosphorylation of Serine Residues in Subcellular and Subnuclear Localization of Transformer-2beta (Tra2beta). J Biol Chem 288: 8898-8909.
54. Cotto J, Fox S, Morimoto R, (1997) HSF1 granules: a novel stress-induced nuclear compartment of human cells. J Cell Sci 110 (Pt 23) (): 2925-2934.
55. Kajita K, Kuwano Y, Kitamura N, Satake Y, Nishida K, et al. (2013) Ets1 and heat shock factor 1 regulate transcription of the Transformer 2beta gene in human colon cancer cells. J Gastroenterol.
56. Ni JZ, Grate L, Donohue JP, Preston C, Nobida N, et al. (2007) Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 21: 708-718.
57. Larsen F, Gundersen G, Prydz H, (1992) Choice of enzymes for mapping based on CpG islands in the human genome. Genet Anal Tech Appl 9: 80-85.
58. Grellscheid S, Dalgliesh C, Storbeck M, Best A, Liu Y, et al. (2011) Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2beta in development. PLoS Genet 7: e1002390.
59. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, et al. (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28: 345-349.